Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2010
08/12/2010US20100203092 Dental, Particularly Remineralizing Composition, Effective for Pain Sensitive Teeth, and Dental Particles, Particularly for Said Composition
08/12/2010US20100203090 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
08/12/2010US20100203089 Selective chemokine modulation
08/12/2010US20100203088 Silver Nanoparticle Dispersion Formulation
08/12/2010US20100203005 Transdermal compositions
08/12/2010US20100202997 Cosmetic Composition for the Hair with a Waxy Effect, in Aerosol Form
08/12/2010US20100202981 Compositions having improved substantivity
08/12/2010US20100202980 Herbal Compositions for the Treatment of Diabetes and/or Conditions Associated Therewith
08/12/2010US20100202979 Compositions and methods for treatment of pulmonary diseases and conditions
08/12/2010US20100202978 Foamable benzoyl peroxide compositions for topical administration
08/12/2010US20100202977 Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
08/12/2010US20100202974 Nano-scale contrast agents and methods of use
08/12/2010US20100202969 Nanoparticles for imaging and treating chlamydial infection
08/12/2010DE102009008256A1 Prodrugs vom Typ N-hydroxylierter Amidine, Guanidine und/oder Aminohydrazone zur Applikation über die Haut Prodrugs of type N-hydroxylated amidines, guanidines and / or Aminohydrazone for application on the skin
08/12/2010CA2752009A1 Orosoluble and/or effervescent compositions containing at least a salt of s-adenosyl methionine (same)
08/12/2010CA2751667A1 Immediate release composition resistant to abuse by intake of alcohol
08/12/2010CA2751633A1 Transdermal pharmaceutical preparations
08/12/2010CA2751627A1 Pharmaceutical compositions resistant to abuse
08/12/2010CA2751460A1 Compositions and uses to govern cancer cell growth
08/12/2010CA2751443A1 Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
08/12/2010CA2751412A1 Methods of reducing the proliferation and viability of microbial agents
08/12/2010CA2751399A1 Buccal application system comprising 17a-estradiol
08/12/2010CA2751331A1 Nanofabricated membrane using polymerized proteoliposomes
08/12/2010CA2751313A1 Process for the preparation of a pharmaceutical composition comprising ezetimibe
08/12/2010CA2750870A1 Method for coating microspheres onto a flexible material
08/12/2010CA2750611A1 Chronotherapeutic pharmaceutical composition
08/12/2010CA2750559A1 Pharmaceutical formulations of tgf-.beta.1 inhibitor peptides
08/12/2010CA2750521A1 Tablets for combination therapy
08/12/2010CA2749809A1 Process for purifying guar
08/12/2010CA2749358A1 A novel cyanopyrimidine derivative
08/12/2010CA2748921A1 Bortezumib containing pharmaceutical composition
08/12/2010CA2746425A1 Clostridial toxin pharmaceutical compositions
08/12/2010CA2741052A1 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
08/12/2010CA2726232A1 Stable formulation of a therapeutic protein
08/11/2010EP2216048A1 Spherical particle and method for producing the same
08/11/2010EP2216042A1 GLP-1 analogues pharmaceutical compositions
08/11/2010EP2216026A1 Ophthalmic compositions and uses for treating ophthalmic conditions
08/11/2010EP2216024A2 Use of Ranolazine for the treatment of cardiovascular diseases
08/11/2010EP2216020A1 Moisture-activated granulation process
08/11/2010EP2216018A1 Transdermal delivery systems
08/11/2010EP2216017A1 Mucosal bioadhesive slow release carrier for delivering active principles
08/11/2010EP2216016A1 Process for the preparation of a pharmaceutical composition comprising ezetimibe
08/11/2010EP2216015A1 Poorly soluble substance-surfactant complex product, and process for production thereof
08/11/2010EP2215168A1 Anti-fouling composition comprising an aerogel
08/11/2010EP2215107A1 Peptide ligand directed drug delivery
08/11/2010EP2214712A1 Compositions and methods for treating asthma and lung disorders
08/11/2010EP2214704A2 Allergen desensitization method
08/11/2010EP2214684A1 Vaginal lubricant comprising hyaluronic acid
08/11/2010EP2214655A1 Compositions containing resveratrol and pectin
08/11/2010EP2214654A2 Method of encapsulation
08/11/2010EP2214653A2 Pharmaceutical compositions containing statins and omega-3 fatty acids derivatives and their solid formulations for oral use
08/11/2010EP2214652A2 Gastrointestinal delivery systems
08/11/2010EP2214651A1 Nifedipine-containing press coated tablet and method of preparing the same
08/11/2010EP2214650A2 Bupropion hydrobromide and therapeutic applications
08/11/2010EP2214649A1 Compositions for treating parkinson's disease
08/11/2010EP2214648A2 Stabilized statins
08/11/2010EP2214647A2 Delivery of active agents
08/11/2010EP2214646A2 Dendrimers for sustained release of compounds
08/11/2010EP2214645A2 Liposomal vancomycin formulations
08/11/2010EP2214644A2 Water-immiscible materials as vehicles for drug delivery
08/11/2010EP2214643A1 Transdermal delivery system for hormones and steroids
08/11/2010EP2214642A1 Topical composition
08/11/2010EP2214641A1 A scalable matrix for the in vivo cultivation of bone and cartilage
08/11/2010EP2214640A1 Intranasal compositions
08/11/2010EP2214639A2 Anesthetic composition, formulation and method of use
08/11/2010EP2214637A1 Stabilized pediatric suspension of carisbamate
08/11/2010EP2214636A1 Oral dosage forms comprising licarbaz pine acetate
08/11/2010EP2214635A1 Solid formulations of crystalline compounds
08/11/2010EP2214482A1 Prostaglandin analog compositions and methods to treat epithelial-related conditions
08/11/2010EP2214480A1 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
08/11/2010EP2214478A1 Composition for administering an active ingredient and method for making and using the same
08/11/2010EP2001451B1 Non-homogenous dosage form coatings
08/11/2010EP1841432B1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
08/11/2010EP1796647B1 Stable pegylated interferon formulation
08/11/2010EP1633327B1 Method for improving stability and shelf-life of liposome complexes
08/11/2010EP1531791B1 Prevention and reduction of ischemia
08/11/2010EP1499294B1 Polymerized lipids modified with peptides used as delivery system for micronutrients
08/11/2010CN201542984U Antineoplastic pill
08/11/2010CN201542983U Easily separable Western medicine tablet
08/11/2010CN201542982U tablet
08/11/2010CN201542981U Cross type cracky tablet
08/11/2010CN201542980U Cross-shaped western medicine tablet
08/11/2010CN201542979U Easily separated western medicine tablet in shape of Chinese character for 'rice'
08/11/2010CN201542978U Western medicine tablet with groove
08/11/2010CN201542977U Easily separable medicine tablet
08/11/2010CN201542976U Novel black plaster with acupuncture point therapeutic function
08/11/2010CN1957980B Composition of medication in use for preserving health and invigorating qi, and preparation method
08/11/2010CN1954843B Traditional Chinese medicine plaster for treating tunica mucosa oris ulcer and its preparation method
08/11/2010CN1943382B Tea capsule and its preparing method
08/11/2010CN1923227B Traditional Chinese medicinal formulation for treating ischemic cardiovascular and cerebrovascular diseases and preparation method thereof
08/11/2010CN1899564B External use medicine for treating hyperosteogeny and protrusion of intervertebral disc
08/11/2010CN1899430B Large size Qingkailing dripping pill and its preparing method
08/11/2010CN1895547B Medicine for treating diabetes and its preparation
08/11/2010CN1886120B Method for the production of a solid, orally applicable pharmaceutical composition
08/11/2010CN1875981B Injection emulsion containing breviscapinum and preparation method thereof
08/11/2010CN1840162B Compound total extract of compound cape jasmine, ginger and fermented soybean, its preparation and use
08/11/2010CN1785247B Disintegrant tablets, and its prepn. method
08/11/2010CN1772189B Auxiliary treating medicine for lung cancer in late stage
08/11/2010CN1672745B Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury
08/11/2010CN1671357B Short duration depot formulations